Synthetic cannabinoids play an important part in the ‘legal high’ market. In Europe, it is the largest chemical group monitored by the European Union’s early warning system, with 30 new products reported in 2012 and 29 in 2013. Although they first appeared in Europe, they are now part of the drugs market in almost all developed countries throughout the world.
This program is compliant with Neptune’s clinical guidance on New Psychoactive Substances and Public Health England’s essential Psycho-social Interventions and Routes to Recovery resources. This ensures your organisation is part of the contemporary solution.
This course ensures that participants are able to:
- Understand some of the history and background of the rising use of Synthetic
- Understand how Synthetic Cannabinoids work and how the effects may differ from
traditional herbal cannabis
- We aware of current patterns of use and prevalence in their local area
- Understand the potential for dependency and problematic use
- Develop harm reduction strategies and techniques to deliver to people who are using
Format: Taught sections, small group work, work in pairs, whole group discussion
Hand-outs: Full hand-outs and sources of further information will be provided